Medical News

Add to Favorites Subscribe Share
newswise-fb-share-

Showing results

5160 of 110717
Newswise: The Medical Minute: Erectile dysfunction both common and treatable

Article ID: 714312

The Medical Minute: Erectile dysfunction both common and treatable

Penn State Health

By age 50, nearly half of men experience some degree of erectile dysfunction. The good news: Several treatment options are available.

Released:
12-Jun-2019 3:05 PM EDT
Newswise: Kids with Headache after Stroke Might be at Risk for Another Stroke

Article ID: 714301

Kids with Headache after Stroke Might be at Risk for Another Stroke

Ann and Robert H. Lurie Children's Hospital of Chicago

A new study has found a high incidence of headaches in pediatric stroke survivors and identified a possible association between post-stroke headache and stroke recurrence.

Released:
12-Jun-2019 2:05 PM EDT
  • Embargo expired:
    12-Jun-2019 2:00 PM EDT

Article ID: 714094

Body Composition Shown to Affect Energy Spent Standing Versus Sitting

PLOS

Findings support increased standing time as a simple way to boost energy expenditure

Released:
7-Jun-2019 9:00 AM EDT
Newswise: ‘Five Star’ Hospitals Often Provide Fewer Services Than Other Hospitals, New Data Suggests

Article ID: 714298

‘Five Star’ Hospitals Often Provide Fewer Services Than Other Hospitals, New Data Suggests

Johns Hopkins Medicine

If you’re looking for a top-notch hospital with a wide range of services, narrowing your list to hospitals with a five-star patient experience rating might lead you astray. Many five-star hospitals offer fewer services than those without five stars, according to a new study by Johns Hopkins researchers published June 10 in JAMA Internal Medicine.

Released:
12-Jun-2019 1:30 PM EDT
Newswise: Researchers develop drug-targeting molecules to improve cancer treatment

Article ID: 714299

Researchers develop drug-targeting molecules to improve cancer treatment

University of Notre Dame

Researchers from the University of Notre Dame have developed small drug-targeting molecules that may be hundreds to thousands of times more effective at delivering potent drugs to desired sites of disease, including cancer.

Released:
12-Jun-2019 1:05 PM EDT
Newswise: New Gene Editor Harnesses Jumping Genes for Precise DNA Integration
  • Embargo expired:
    12-Jun-2019 1:00 PM EDT

Article ID: 714251

New Gene Editor Harnesses Jumping Genes for Precise DNA Integration

Columbia University Irving Medical Center

Scientists at Columbia have developed a gene-editing tool—using jumping genes—that inserts any DNA sequence into the genome without cutting, fixing a major shortcoming of existing CRISPR technology.

Released:
11-Jun-2019 2:05 PM EDT
Newswise: Study identifies promising target for Parkinson’s intervention

Article ID: 714292

Study identifies promising target for Parkinson’s intervention

University of Alabama at Birmingham

An international research team led by scientists at UAB has identified a fibril form of alpha-synuclein as a potential target for therapeutics that might help slow the progression of Parkinson’s disease.

Released:
12-Jun-2019 12:05 PM EDT
UAMS_Qualifier_RGB.jpg

Article ID: 714295

UAMS-Developed Cytophone Detects Melanoma in Earliest Stages, Could Prevent Fatal Disease Spread

University of Arkansas for Medical Sciences

A University of Arkansas for Medical Sciences (UAMS) research team led by Vladimir Zharov, Ph.D., D.Sc., has demonstrated the ability to detect and kill circulating tumor cells (CTCs) in the blood using a noninvasive device called Cytophone that integrates a laser, ultrasound and phone technologies. This device is 1,000 times more sensitive than other methods at detecting of CTCs in the blood of patients with melanoma, a deadly form of skin cancer.

Released:
12-Jun-2019 12:05 PM EDT
Embargo will expire:
24-Jun-2019 1:05 AM EDT
Released to reporters:
12-Jun-2019 12:05 PM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 24-Jun-2019 1:05 AM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

NYULangoneHealthLogo.jpg

Article ID: 714287

NYU Langone Performs First U.S. Procedure with Newly Approved Device to Reduce Herniated Disc Recurrence

NYU Langone Health

NYU Langone performs first U.S. procedure using newly approved device to reduce risk of repeat surgeries for herniated disc

Released:
12-Jun-2019 12:00 PM EDT

Channels:

Bone Health, Pain, Surgery

Languages:

English


Showing results

5160 of 110717

Chat now!